Emily S Ruiz, MD, FAAD
SESSIONS
F040 Respect the Dormant Beast: Optimize Your Management of High-Risk Cutaneous SCCs
Mar 28, 2026
•
1:00 PM - 3:00 PM
•
Mile High 2C
F088 Skin Disease in Transplant Recipients and Immunosuppressed Patients
Mar 30, 2026
•
1:00 PM - 3:00 PM
•
Mile High 3A
DISCLOSURES
Almirall – Consultant (1099 relationship)(Fees); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Checkpoint Therapeutics – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Merck – Investigator(Grants/Research Funding); Regeneron – Advisory Board(Fees), Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees), Consultant (1099 relationship)(Fees);